Hormone replacement therapy helps relieve postmenopausal symptoms such as hot flushes and night sweats by replacing hormones that a woman's body is not producing enough

Certain hormone replacement therapy (HRT) tablets containing both estrogen and progestogen are associated with a higher risk of heart disease and rare but serious blood clots known as venous thromboembolism (VTE) in women around the age of menopause,

New study finds using oral combined continuous therapy was associated with increased risk of ischemic heart disease

WOMEN taking certain types of hormone replacement therapy (HRT) drugs containing both oestrogen and progesterone could be at higher risk of heart disease, a new study has found. HRT is used to

Estrogen/progestin pills increased women’s risk of heart disease by 21% and risk of life-threatening blood clots by 61%, researchers found. Similarly, the synthetic hormone pill tibolone increased risk of heart disease by 46% and nearly doubled the risk of stroke and heart attack,

Researchers analysed almost a million women in Sweden and found those taking certain HRT tablets suffered higher rates of heart complications and blood clots. The number of women using the treatment in England has surged to about 2.